Indian Army Pharmaceutical Supply: Essential Medications Procurement

This tender description outlines an opportunity for the supply of critical pharmaceutical products to the Indian Army, under the purview of the Department of Military Affairs within the Ministry of Defence. Identified by Bid Number GEM/2026/B/8013916, this procurement seeks to fulfill a total quantity of 9525 units of various medications. The bidding period commences on October 6, 2026, at 6:00 PM and concludes on October 7, 2026, at 6:00 PM. The specified items include Thiocolchiside 4 mg Tablets, Pyridostigmine 60 mg Tablets, Misoprostol 25 mg Tablets, Linagliptin 2.5 mg plus Metformin 1000 mg Tablets, Linagliptin 2.5 mg plus Metformin 500 mg Tablets, Glibenclamide 5 mg Tablets, Misoprostol 100 mg Tablets, Mesna 200 mg Injection, Selegiline 5 mg Tablets, and Ethamsylate 250mg Tablets. Prospective suppliers are invited to submit their proposals for this significant requirement, contributing to the healthcare provisions of the Indian Army.